Evaluation of the PPAR-[gamma] agonist pioglitazone in mild asthma: A double-blind randomized controlled trial

Peroxisome proliferator-activated receptor gamma (PPAR-[gamma]) is a nuclear receptor that modulates inflammation in models of asthma. To determine whether pioglitazone improves measures of asthma control and airway inflammation, we performed a single-center randomized, double-blind, placebo-control...

Full description

Bibliographic Details

Published in:	PloS one Vol. 11; no. 8; p. e0160257
Main Authors:	Anderson, J. R, Mortimer, K, Pang, L, Smith, K. M, Bailey, H, Hodgson, D. B, Shaw, D. E, Knox, A. J, Harrison, T. W
Format:	Journal Article
Language:	English
Published:	Public Library of Science 25.08.2016
Subjects:	Asthma Care and treatment Clinical trials Complications and side effects Health aspects Influence Pioglitazone Vascular endothelial growth factor United Kingdom
ISSN:	1932-6203, 1932-6203
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!